Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment.

Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment. — المؤلف: Yu, Qian — Cell death & disease 20200506

المؤلف
Yu, Qian
النشر
Cell death & disease 20200506
الوصف
218 p.
الموضوعات
Animals؛ Carcinoma, Non-Small-Cell Lung؛ Cell Line, Tumor؛ Cell Proliferation؛ DNA-Binding Proteins؛ Epithelial-Mesenchymal Transition؛ G2 Phase Cell Cycle Checkpoints؛ Gene Expression Regulation, Neoplastic